Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colorectal CancerJianxia Li, Yanhong Deng, Jianwei Zhang et al.|Clinical Cancer Research|2023Cited by 33
Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapyGe Qin, Yanhong Deng, Fan Bai et al.|Molecular Medicine|2024Cited by 21
Clinicopathological, Molecular Features and Prognosis of Colorectal Cancer with Mucinous ComponentJianxia Li, Yanhong Deng, Yang Liu et al.|Future Oncology|2020Cited by 16
LncRNA ENSG00000254615 Modulates Proliferation and 5-FU Resistance by Regulating p21 and Cyclin D1 in Colorectal CancerYang Fu, Yanhong Deng, Xiaoyu Xie et al.|Cancer Investigation|2021Cited by 9